Nanoview Biosciences

Nanoview Biosciences

Developing proprietary products that support research, translation and delivery of precision medicine.

Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Oct 2018.)
Boston Massachusetts (HQ & founding location)
  • Edit
DateInvestorsAmountRound

N/A

Grant

$450k

Grant

N/A

Series A
*

$10.0m

Series B

$6.0m

Series B
*

$200k

Grant
*
N/A

$2.5m

Debt
*

N/A

Acquisition
Total Funding€15.1m

Recent News about Nanoview Biosciences

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.